Search

The pharmaceutical sector launched a Framework for Action to tackle non-communicable diseases including cardiovascular disease, cancer, diabetes and chronic respiratory diseases that are posing a threat to public health, and public and private finances worldwide.

By focussing in on the research function, international university rankings are giving a skewed picture and pushing investments towards things that improve an institution’s position, and away from core activities like teaching.

The latest Eurobarometer report shows citizens have concerns about the security and privacy of their data online. This is holding back the development of Europe’s single digital market, says the Commission

The increasing incursion of social media into our professional and personal lives and shared data storage in the Cloud makes the question of data protection and security ever-more urgent. The answer won’t come from technology alone, but will need to embrace research and policy

With around 400,000 students, five of the UK’s top 10 research institutions, and more than 20 Nobel prize winners, London has as much claim to be the centre of the country’s science as Oxford or Cambridge. So why does it have such a hard job holding on to its spin-out companies, particularly in life sciences?

US/European move to put more weight behind moves to improve drug development processes and increase’s R&D productivity in the pharmaceutical industry

Following the deadly outbreak of E. coli infections in Germany, scientists in Saarbruecken are providing free access to the pathogen’s genetic regulation data, to spur research into new antibiotics

The Helmholtz is to lead a major investigation into the sustainable development of rice ecosystems in Southeast Asia involving 22 research institutions

The UK climate minister Greg Barker has announced cuts to the feed-in tariff for all solar installations above 50kw, a move of huge significance to the industry

It’s widely accepted that intellectual property and equity are essential ingredients for a start-up. But this is not true in every case